Skip to the page

Data / Drug companies / Penem Antibacterial

Penem Antibacterial drugs: 8 drugs from 25 companies in the FDA NDC directory

Penem Antibacterial is an FDA established pharmacologic class. The FDA National Drug Code Directory lists 80 products in this class from 25 companies, covering 8 drugs by generic name. The main marketing category is generic drugs (ANDA), and the newest product started marketing on October 1, 2026.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

  • 25Companies
  • 80Products
  • 8Drugs by generic name

Drugs in the Penem Antibacterial class

Ranked by number of companies that list the drug.

DrugProducts hereCompanies listing it
Meropenem4717
Ertapenem sodium1511
Ertapenem65
Imipenem and cilastatin sodium72
Meropenem and sodium chloride21
Imipenem and cilastatin11
Imipenem anhydrous, cilastatin, and relebactam anhydrous11
Meropenem-vaborbactam11

Companies with the most products in this class

CompanyProductsMain dosage formsMain marketing categoryNewest product started
Fresenius Kabi USA, LLC13injection, powder, for solution; injection, powder, lyophilized, for solutionGeneric drugs (ANDA)October 10, 2019
WG Critical Care, LLC7injection, powder, for solution; injection, powder, lyophilized, for solutionGeneric drugs (ANDA)September 8, 2023
Hikma Pharmaceuticals USA Inc.6injection, powder, lyophilized, for solution; injectionGeneric drugs (ANDA)August 25, 2026
Hospira, Inc.5injection, powder, for solution; injection, powder, lyophilized, for solutionGeneric drugs (ANDA)December 6, 2022
Civica, Inc.4injectionGeneric drugs (ANDA)September 8, 2025
Eugia US LLC4injection, powder, for solution; injectionGeneric drugs (ANDA)June 25, 2018
Sagent Pharmaceuticals4injection, powder, for solution; injection, powder, lyophilized, for solutionGeneric drugs (ANDA)January 15, 2026
BluePoint Laboratories3injection, powder, for solution; injectionGeneric drugs (ANDA)August 29, 2019
Brooks Steriscience Limited3injectionGeneric drugs (ANDA)June 27, 2025
Gland Pharma Limited3injection; injection, powder, lyophilized, for solutionGeneric drugs (ANDA)March 26, 2021
Merck Sharp & Dohme LLC3injection, powder, for solution; injection, powder, lyophilized, for solutionNew drug applications (NDA)January 6, 2020
Qilu Antibiotics Pharmaceutical Co., Ltd.3injection; injection, powder, lyophilized, for solutionGeneric drugs (ANDA)December 30, 2024
Savior Lifetec Corporation3injectionGeneric drugs (ANDA)March 19, 2019
Amneal Pharmaceuticals LLC2injection, powder, for solutionGeneric drugs (ANDA)May 9, 2016
Apotex Corp.2injectionGeneric drugs (ANDA)October 1, 2026
Armas Pharmaceuticals Inc.2injectionGeneric drugs (ANDA)August 10, 2023
B. Braun Medical Inc.2injection, solutionNew drug applications (NDA)April 30, 2015
Par Health USA, LLC2injection, powder, lyophilized, for solutionNew drug applications (NDA)November 1, 2018
Sandoz Inc2injectionGeneric drugs (ANDA)August 29, 2016
Xellia Pharmaceuticals USA LLC2injection, powder, for solutionGeneric drugs (ANDA)June 28, 2021
Dr. Reddy's Laboratories Inc.1injection, powder, lyophilized, for solutionGeneric drugs (ANDA)April 29, 2021
Fosun Pharma USA Inc.1injection, powder, lyophilized, for solutionGeneric drugs (ANDA)November 1, 2021
Melinta Therapeutics, LLC1injection, powder, for solutionNew drug applications (NDA)October 2, 2017
Mylan Institutional LLC1injectionGeneric drugs (ANDA)July 1, 2025
NorthStar Rx LLC1injection, powder, lyophilized, for solutionGeneric drugs (ANDA)July 13, 2021

Dosage forms

Dosage formProductsShare
Injection, powder, for solution3746.2%
Injection2632.5%
Injection, powder, lyophilized, for solution1518.8%
Injection, solution22.5%

Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.